DINAMIQS
Schlieren (Zurich), Switzerland
Program data pending ClinicalTrials.gov matching
· Last scored 2026-04-30
66.5
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
○ Press
○ EMA GMP
○ MHRA GMP
Quick Facts: DINAMIQS
- Signal Score
- 66.5/100 (as of 2026-04-30)
- Quality Compliance
- Assessment pending
- Headquarters
- Schlieren (Zurich), Switzerland
- Founded
- 2021
- Max Bioreactor Scale
- 1000L (2x 500L)
- Website
- https://dinamiqs.com/
- Modalities
- AAV, Lentivirus
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About DINAMIQS
Auto-created by AI matchmaker. Data verification pending.
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesAAV, Lentivirus
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
75.0
Strong parent backing: Siegfried Holding AG
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Strong parent backing: Siegfried Holding AG
Capacity
58.0
1 manufacturing site: Zurich (Schlieren), Switzerland
Modalities: AAV, Lentivirus
Capacity assessment: 58.0/100
Sites: Zurich (Schlieren), Switzerland
Source: SEC EDGAR, press monitoring, company profiles
1 manufacturing site
StatusAvailable
1 manufacturing site: Zurich (Schlieren), Switzerland
Modalities: AAV, Lentivirus
Capacity assessment: 58.0/100
Sites: Zurich (Schlieren), Switzerland
1 manufacturing site: Zurich (Schlieren), Switzerland
Modalities: AAV, Lentivirus
Capacity assessment: 58.0/100
Frequently Asked Questions About DINAMIQS
What is DINAMIQS's CDMO Signal Score?
DINAMIQS has a Signal Score of 66/100, based on quality, operations, financial stability, and capacity data.
Evaluating DINAMIQS for a manufacturing program?
Use the free AI matchmaker to compare DINAMIQS against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Lonza
Basel, Switzerland
Signal Score: 78.2
AAV, Lentiviral, Cell Therapy, mRNA
Celonic
Basel, Switzerland
Signal Score: 78.1
AAV, Cell Therapy
Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 91.7
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral
ReciBioPharm
Keele, UK · Sodertalje, SE
Signal Score: 88.0
AAV, Lentiviral, Plasmid, mRNA
Pharmaron Biologics
San Diego, CA · Shaoxing, CN
Signal Score: 85.6
AAV, Lentiviral, Plasmid